Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series.
Clairelyne DupinSolène ValéryLaurent GuilleminaultGilles DevouassouxMarine MerveilleauMaud RussierGisèle MourinJohana PradelliPhilippe BonniaudMathilde Le BrunEsther EbsteinPierre-Antoine JugeAgnès Lillo-LelouetCamille TailléPublished in: ERJ open research (2024)
Articular manifestations should be screened before and during anti-IL-5/5R biologic treatment in severe asthma. Rigorous multidisciplinary team discussion should be carried out to assess the risk-benefit balance of withholding effective treatment. https://bit.ly/3vfPn4k.
Keyphrases